<![CDATA[Cervical cancer is a malignancy characterized by the uncontrolled growth of abnormal cells in the cervix that can spread to the uterus and vagina. Persistent infection with the Human Papillomavirus (HPV) is the primary cause of this disease. This study aimed to examine the correlations between sexual function, husband support, and the quality of life of patients with cervical cancer undergoing chemotherapy. This quantitative study employed a cross-sectional design. The researchers recruited 121 patients with cervical cancer at Dr. Moewardi Regional General Hospital, Surakarta, using consecutive sampling between May 4 and May 28, 2026. They assessed sexual function using the Female Sexual Function Index (FSFI), measured husband support with a husband support questionnaire, and evaluated quality of life using the Indonesian version of the World Health Organization Quality of Life–BREF (WHOQOL-BREF). Most respondents were 36–45 years old 92 (76.0%), had completed elementary school as their highest level of education 45 (37.2%), were unemployed 110 (90.9%), had stage III cervical cancer 60 (49.9%), had received chemotherapy for less than six months 77 (63.6%), had previously undergone radiotherapy 85 (70.2%), and received platinum- and taxane-based combination chemotherapy 117 (96.7%). In addition, 115 respondents (95.0%) experienced sexual dysfunction, 70 (57.9%) reported moderate husband support, and 75 (62.0%) had poor quality of life. Spearman's rank correlation analysis showed a significant correlation between sexual function and quality of life (p = 0.001). The correlation coefficient (r = 0.292) indicated a weak positive correlation. Husband support also showed a significant correlation with quality of life (p < 0.001), with a weak positive correlation (r = 0.336), indicating that stronger husband support was associated with better quality of life.]]>
